ArticleCancer research2019

Correction: Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population.

Neil E Bhola et al.PubMed ↗Publisher ↗

No numbers read from the abstract.